Sheila Keating, Ph.D.
Vice President, Immunology
Dr. Keating has over 20 years experience in infectious disease, immunopathology, and translational immunology. She leads clinical development of GigaGen’s recombinant hyperimmune gammaglobulin product in collaboration with pharmaceutical partner Grifols. Prior to joining GigaGen, Dr. Keating was the Director of the Core Immunology Laboratory at Blood Systems Research Institute (BSRI) in San Francisco. BSRI provides high throughput immunological analysis for large scale medical research projects in the US and internationally. Dr. Keating has spent her career advancing the diagnosis and treatment of infectious and chronic disease through the study of immune biomarkers and immunopathology. She has been the recipient of multiple research grants and has led both pre-clinical and clinical projects in translational immunology research. Dr. Keating received a Ph.D. in Immunology at Oxford University in Oxford, UK, a MSPH in Epidemiology and Tropical Medicine at Tulane University in New Orleans, LA, and a BA in Biology at College of Holy Cross in Worcester in MA. She is an Adjunct Associate Professor at the University of California, San Francisco, and has authored over eighty publications.